{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:31:16Z","timestamp":1793449876715,"version":"4.5.0"},"reference-count":34,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2020,5,22]]},"abstract":"<jats:p>Many H5 and H7 subtype avian influenza vaccines are poorly immunogenic in terms of inducing hemagglutination-inhibition (HI) antibody titers. Residue 227 (H3 numbering) in the receptor binding site in the hemagglutinin (HA) is critical for the detectability of HI antibodies induced by H5 influenza vaccines. However, whether the effect of residue 227 on immunogenicity can be generalized in different subtypes is unclear. In this study, the impact of HA residue 227 on immunogenicity of H5N1, H5N6, and H7N9 avian influenza vaccines was evaluated in chickens. Polymorphism analysis revealed that S227 is overwhelmingly dominant in HA of the H5N1 and H7N9 subtypes, whereas this amino acid is present in a small proportion of H5N6 viruses. The H5N1, H5N6, and H7N9 vaccines harboring S227 in HA induced relatively low HI titers at week 2 postimmunization (pi), and antibody titers increased at week 3 pi. S227N substitution in these vaccines consistently enhanced HI titers significantly. Another H5N6 vaccine harboring Q227 in HA elicited a robust HI antibody response, and Q227S substitution led to a significant drop of HI titers. Cross-HI testing against the wild-type and mutant viruses revealed that the amino acid at position 227 was associated with the detectability of HI titers induced by H5 and H7 avian influenza vaccines. The results indicate an important role of residue 227 in HA in immunogenicity of H5 and H7 subtype avian influenza vaccines in chickens. Our findings also provided useful information for vaccine seed virus selection and genetic engineering for immunogenicity enhancement of avian influenza vaccines.<\/jats:p>","DOI":"10.1637\/aviandiseases-d-20-00013","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T06:57:08Z","timestamp":1608101828000},"page":"445-450","source":"Crossref","is-referenced-by-count":2,"title":["Role of the Hemagglutinin Residue 227 in Immunogenicity of H5 and H7 Subtype Avian Influenza Vaccines in Chickens"],"prefix":"10.1637","volume":"64","author":[{"given":"Zenglei","family":"Hu","sequence":"first","affiliation":[{"name":"Institutes of Agricultural Science and Technology Development, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gu","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoquan","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Liu","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunlin","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gu","sequence":"additional","affiliation":[{"name":"Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Cao","sequence":"additional","affiliation":[{"name":"Institutes of Agricultural Science and Technology Development, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufan","family":"Liu","sequence":"additional","affiliation":[{"name":"Institutes of Agricultural Science and Technology Development, Yangzhou University, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1212","reference":[{"key":"34","doi-asserted-by":"crossref","unstructured":"M Oliveira Cavalcanti, E Vaughn, I Capua, et al.  \"Avian Pathol.\"  46, \"A genetically engineered H5 protein expressed in insect cells confers protection against different clades of H5N1 highly pathogenic avian influenza viruses in chickens.\" 224 (2017)","DOI":"10.1080\/03079457.2016.1250866"},{"key":"1","unstructured":"K Thurain, PP Mon, C Nasamran, et al.  \"Transbound Emerg Dis.\"  , \"Surveillance of influenza A virus subtype H5N1 in a live bird market in Yangon, Myanmar: 2017\u20132018.\"  ()"},{"key":"2","doi-asserted-by":"crossref","unstructured":"J Shin, S Kang, H Byeon, et al.  \"Sci Rep.\"  10, \"Highly pathogenic H5N6 avian influenza virus subtype clade 2.3.4.4 indigenous in South Korea.\" 7241 (2020)","DOI":"10.1038\/s41598-020-64125-x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"S Barman, JCM Turner, MK Hasan, et al.  \"Emerg Microbes Infect.\"  8, \"Continuing evolution of highly pathogenic H5N1 viruses in Bangladeshi live poultry markets.\" 650 (2019)","DOI":"10.1080\/22221751.2019.1605845"},{"key":"4","doi-asserted-by":"crossref","unstructured":"T Usui, K Soda, K Sumi, et al.  \"Transbound Emerg Dis.\"  67, \"Outbreaks of highly pathogenic avian influenza in zoo birds caused by HA clade 2.3.4.4 H5N6 subtype viruses in Japan in winter 2016.\" 686 (2020)","DOI":"10.1111\/tbed.13386"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Y Bi, Q Chen, Q Wang, et al.  \"Cell Host Microbe.\"  20, \"Genesis, evolution and prevalence of H5N6 avian influenza viruses in China.\" 810 (2016)","DOI":"10.1016\/j.chom.2016.10.022"},{"key":"6","doi-asserted-by":"crossref","unstructured":"J Yang, Z Wang, Y Du, et al.  \"Vet Microbiol.\"  235, \"Clade 2.3.2.1 H5N1 avian influenza viruses circulate at the interface of migratory and domestic birds around Qinghai Lake in China.\" 234 (2019)","DOI":"10.1016\/j.vetmic.2019.07.009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"R Gao, B Cao, Y Hu, et al.  \"N Engl J Med.\"  368, \"Human infection with a novel avian-origin influenza A (H7N9) virus.\" 1888 (2013)","DOI":"10.1056\/NEJMoa1304459"},{"key":"8","doi-asserted-by":"crossref","unstructured":"X Wang, H Jiang, P Wu, et al.  \"Lancet: Infect Dis.\"  17, \"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013\u201317: an epidemiological study of laboratory-confirmed case series.\" 822 (2017)","DOI":"10.1016\/S1473-3099(17)30323-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"WB Qi, WX Jia, D Liu, et al.  \"J Virol.\"  92, \"Emergence and adaptation of a novel highly pathogenic H7N9 influenza virus in birds and humans from a 2013 human-infecting low-pathogenic ancestor.\" e00921 (2018)","DOI":"10.1128\/JVI.00921-17"},{"key":"10","doi-asserted-by":"crossref","unstructured":"J Shi, G Deng, S Ma, et al.  \"Cell Host Microbe.\"  24, \"Rapid evolution of H7N9 highly pathogenic viruses that emerged in China in 2017.\" 558.e7 (2018)","DOI":"10.1016\/j.chom.2018.08.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"S Refaey, E Azziz-Baumgartner, MM Amin, et al.  \"Emerg Infect Dis.\"  21, \"Increased number of human cases of influenza virus A(H5N1) infection, Egypt, 2014\u201315.\" 2171 (2015)","DOI":"10.3201\/eid2112.150885"},{"key":"12","doi-asserted-by":"crossref","unstructured":"A Gambotto, SM Barratt-Boyes, MD de Jong, et al.  \"Lancet.\"  371, \"Human infection with highly pathogenic H5N1 influenza virus.\" 1464 (2008)","DOI":"10.1016\/S0140-6736(08)60627-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Y Bi, S Tan, Y Yang, et al.  \"Clin Infect Dis.\"  68, \"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus.\" 1100 (2019)","DOI":"10.1093\/cid\/ciy681"},{"key":"14","doi-asserted-by":"crossref","unstructured":"TM Uyeki  and M Peiris  \"Infect Dis Clinics N Am.\"  33, \"Novel avian influenza A virus infections of humans.\" 907 (2019)","DOI":"10.1016\/j.idc.2019.07.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"KG Nicholson, AE Colegate, A Podda, et al.  \"Lancet.\"  357, \"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.\" 1937 (2001)","DOI":"10.1016\/S0140-6736(00)05066-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"J Pfeiffer, DL Suarez, L Sarmento, et al.  \"Avian Dis.\"  54, \"Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam.\" 262 (2010)","DOI":"10.1637\/8715-031909-Reg.1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"LA Jackson, JD Campbell, SE Frey, et al.  \"J Am Med Assoc.\"  314, \"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial.\" 237 (2015)","DOI":"10.1001\/jama.2015.7916"},{"key":"18","doi-asserted-by":"crossref","unstructured":"I Isakova-Sivak  and L Rudenko  \"Expert Rev Vaccines.\"  16, \"Tackling a novel lethal virus: a focus on H7N9 vaccine development.\" 1 (2017)","DOI":"10.1080\/14760584.2017.1333907"},{"key":"19","doi-asserted-by":"crossref","unstructured":"RP Kamal, K Blanchfield, JA Belser, et al.  \"J Virol.\"  91, \"Inactivated H7 influenza virus vaccines protect mice despite low levels of neutralizing antibodies.\" e01202 (2017)","DOI":"10.1128\/JVI.01202-17"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Z Hu, X Liu, X Jiao,  \"Vaccine.\"  35, \"Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.\" 6585 (2017)","DOI":"10.1016\/j.vaccine.2017.10.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"SA Bart, M Hohenboken, G Della Cioppa, et al.  \"Sci Transl Med.\"  6, \"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults.\" 234ra255 (2014)","DOI":"10.1126\/scitranslmed.3008761"},{"key":"22","doi-asserted-by":"crossref","unstructured":"F Krammar  and RJ Cox  \"Expert Rev Vaccines.\"  12, \"The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines.\" 1369 (2013)","DOI":"10.1586\/14760584.2013.850036"},{"key":"23","doi-asserted-by":"crossref","unstructured":"S Black, U Nicolay, T Vesikari, et al.  \"Pediatr Infect Dis J.\"  30, \"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.\" 1081 (2011)","DOI":"10.1097\/INF.0b013e3182367662"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Q Xu, W Wang, X Cheng, et al.  \"J Virol.\"  84, \"Influenza H1N1 A\/Solomon Island\/3\/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets.\" 4936 (2010)","DOI":"10.1128\/JVI.02489-09"},{"key":"25","doi-asserted-by":"crossref","unstructured":"L Xu, L Bao, SY Lau, et al.  \"Vaccine.\"  34, \"Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.\" 2627 (2016)","DOI":"10.1016\/j.vaccine.2016.03.031"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Z Chen, H Zhou, L Kim, et al.  \"J Virol.\"  86, \"The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.\" 2780 (2012)","DOI":"10.1128\/JVI.06219-11"},{"key":"27","doi-asserted-by":"crossref","unstructured":"E Hoffmann, AS Lipatov, RJ Webby, et al.  \"Proc Natl Acad Sci U S A.\"  102, \"Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines.\" 12915 (2005)","DOI":"10.1073\/pnas.0506416102"},{"key":"28","doi-asserted-by":"crossref","unstructured":"WJ Wang, B Lu, HL Zhou, et al.  \"J Virol.\"  84, \"Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A\/Vietnam\/1203\/2004 vaccine virus in ferrets.\" 6570 (2010)","DOI":"10.1128\/JVI.00221-10"},{"key":"29","doi-asserted-by":"crossref","unstructured":"AS Lipatov, E Hoffmann, R Salomon, et al.  \"J Infect Dis.\"  194, \"Cross-protectiveness and immunogenicity of influenza A\/Duck\/Singapore\/3\/97(H5) vaccines against infection with A\/Vietnam\/1203\/04(H5N1) virus in ferrets.\" 1040 (2006)","DOI":"10.1086\/507709"},{"key":"30","doi-asserted-by":"crossref","unstructured":"W Sun, J Li, J Hu, et al.  \"Vet Microbiol.\"  219, \"Genetic analysis and biological characteristics of different internal gene origin H5N6 reassortment avian influenza virus in China in 2016.\" 200 (2018)","DOI":"10.1016\/j.vetmic.2018.04.023"},{"key":"31","doi-asserted-by":"crossref","unstructured":"L He, D Liu, J Hu, et al.  \"Transbound Emerg Dis.\"  65, \"A comprehensive comparison of the fifth-wave highly pathogenic and low-pathogenic H7N9 avian influenza viruses reveals potential threat posed by both types of viruses in mammals.\" 1459 (2018)","DOI":"10.1111\/tbed.12954"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Z Hu, J Zhao, Y Zhao, et al.  \"Front Vet Sci.\"  6, \"Hemagglutinin-specific non-neutralizing antibody is essential for protection provided by inactivated and viral-vectored H7N9 avian influenza vaccines in chickens.\" 482 (2020)","DOI":"10.3389\/fvets.2019.00482"},{"key":"33","unstructured":"et al.  \"Prism, version 8.0.\"  ,  (2018)"}],"container-title":["Avian Diseases"],"original-title":[],"link":[{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-64\/issue-4\/aviandiseases-D-20-00013\/Role-of-the-Hemagglutinin-Residue-227-in-Immunogenicity-of-H5\/10.1637\/aviandiseases-D-20-00013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:44:42Z","timestamp":1793447082000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-64\/issue-4\/aviandiseases-D-20-00013\/Role-of-the-Hemagglutinin-Residue-227-in-Immunogenicity-of-H5\/10.1637\/aviandiseases-D-20-00013.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-20-00013","relation":{},"ISSN":["0005-2086","1938-4351"],"issn-type":[{"value":"0005-2086","type":"print"},{"value":"1938-4351","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}